The apoptosis and subsequent clearance of eosinophils without histotoxic mediator release is thought to be crucial in the resolution of airway inflammation in asthma. Interleukin-5 (IL-5) is a potent suppressor of eosinophil apoptosis. The mechanism by which IL-5 inhibits spontaneous eosinophil apoptosis was investigated. Freshly isolated eosinophils constitutively expressed the conformationally active form of Bax in the cytosol and nucleus. During spontaneous and staurosporine-induced apoptosis, Bax underwent a caspase-independent translocation to the mitochondria, which was inhibited by IL-5. Eosinophil apoptosis was associated with the release of cytochrome c from the mitochondria, which was also inhibited by IL-5. IL-5 and the cell-permeable caspase inhibitor, benzyloxycarbonyl-Val-Ala-Asp-(OMe) fluoromethyl ketone (z-VAD.fmk), prevented phosphatidylserine (PS) externalization, although only IL-5 inhibited loss of mitochondrial membrane potential (⌬⌿m). Peripheral blood eosinophils endogenously expressed "initiator" caspase-8 and -9, and "effector" caspase-3, -6, and -7. Spontaneous eosinophil apoptosis was associated with processing of caspase-3, -6, -7, -8, and -9. IL-5 and z-VAD.fmk prevented caspase activation in spontaneous apoptosis. The results suggest that spontaneous eosinophil apoptosis involves Bax translocation to the mitochondria, cytochrome c release, caspase-independent perturbation of the mitochondrial membrane, and subsequent activation of caspases. IL-5 inhibits spontaneous eosinophil apoptosis at a site upstream of Bax translocation.
IntroductionEosinophils play a pivotal role in the pathogenesis of asthma and allergic disease. 1,2 Apoptosis and efficient clearance of apoptotic cells without histotoxic mediator release is thought to be crucial in the resolution of airway inflammation, 3 and delayed eosinophil apoptosis has an association with asthma, inhalant allergy, and atopic dermatitis. 4,5 The accumulation and persistence of eosinophils at sites of inflammation are mediated at least in part by extended survival in response to circulating hematopoietins interleukin-3 (IL-3), IL-5, and granulocyte-macrophage colony-stimulating factor (GM-CSF). Eosinophils rapidly undergo apoptosis unless exposed to these cytokines in vitro 6,7 and in vivo. 8,9 The mechanism by which IL-5 prevents apoptosis in eosinophils is largely unknown.The Bcl-2 homologues are critical regulators of the apoptotic pathway, with interactions between proapoptotic (Bax, Bik, Bim, Bak) and antiapoptotic (Bcl-2, Bcl-x L ) proteins controlling the release of apoptogenic factors from mitochondria 10,11 and subsequent activation of caspases, the conserved death proteases of the cell. Previous reports investigating the role of Bcl-2 homologues in eosinophils have concentrated on the level of protein expression. Human peripheral blood eosinophils endogenously express relatively high levels of proapoptotic Bax and antiapoptotic Bcl-x L , with little or no detectable antiapoptotic Bcl-2 expression, 12,13 although there is some ...